From the American Academy of Ophthalmology

Investigators subjected data from an Impact of Vision Impairment questionnaire to Rasch analysis, and found that a change in vision in eyes treated with anti-VEGF for wet AMD directly influenced patients' reported vision-related quality of life, whether the better or worse eye was treated. A gain vision improved self-reported ability to read and access information, as well as emotional well-being. They conclude that even worse eyes should receive treatment and that any treatment should aim to at least maintain vision in the treated eye because anything leading to a >2-line loss will lead to a significant loss of vision-related quality of life, even over one year of follow-up. Ophthalmology, June 2014